ID   SMS-KANR
AC   CVCL_7132
DR   Cosmic; 922672
DR   Cosmic; 1890105
DR   Wikidata; Q54954988
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=8665486;
RX   PubMed=23202128;
WW   http://www.cccells.org/dl/NB_Data_Sheets/SMS-KANR_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: ~69 hours (PubMed=3456456).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 17,21
ST   D19S433: 12
ST   D21S11: 28,30
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 19,21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7131 ! SMS-KAN
SX   Female
AG   3Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   DOI=10.1007/0-306-46872-7_2;
RA   Thiele C.J.;
RT   "Neuroblastoma.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999).
//
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RA   Biedler J.L., Meyers M.B., Spengler B.A.;
RT   "Homogeneously staining regions and double minute chromosomes,
RT   prevalent cytogenetic abnormalities of human neuroblastoma cells.";
RL   (In book chapter) Advances in cellular neurobiology, Vol. 4; Fedoroff S., Hertz L. (eds.); pp.267-307; Academic Press; New York; USA (1983).
//
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RA   Israel M.A., Thiele C.J.;
RT   "Tumor cell lines of the peripheral nervous system.";
RL   (In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York; USA (1994).
//
RX   PubMed=3456456; DOI=10.1093/jnci/76.3.375;
RA   Reynolds C.P., Biedler J.L., Spengler B.A., Reynolds D.A., Ross R.A.,
RA   Frenkel E.P., Smith R.G.;
RT   "Characterization of human neuroblastoma cell lines established before
RT   and after therapy.";
RL   J. Natl. Cancer Inst. 76:375-387(1986).
//
RX   PubMed=7037175;
RA   Reynolds C.P., Reynolds D.A., Frenkel E.P., Smith R.G.;
RT   "Selective toxicity of 6-hydroxydopamine and ascorbate for human
RT   neuroblastoma in vitro: a model for clearing marrow prior to
RT   autologous transplant.";
RL   Cancer Res. 42:1331-1336(1982).
//
RX   PubMed=8665486; DOI=10.1016/0304-3835(96)04250-4;
RA   Diccianni M.B., Chau L.S., Batova A., Vu T.Q., Yu A.L.-T.;
RT   "The p16 and p18 tumor suppressor genes in neuroblastoma: implications
RT   for drug resistance.";
RL   Cancer Lett. 104:183-192(1996).
//
RX   PubMed=23202128; DOI=10.1038/ng.2493; PMCID=PMC3557959;
RA   Sausen M., Leary R.J., Jones S., Wu J., Reynolds C.P., Liu X.-Y.,
RA   Blackford A.L., Parmigiani G., Diaz L.A. Jr., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E., Hogarty M.D.;
RT   "Integrated genomic analyses identify ARID1A and ARID1B alterations in
RT   the childhood cancer neuroblastoma.";
RL   Nat. Genet. 45:12-17(2013).
//